Recombinant Proteins Market Size Worth $7.53 Billion By 2034 | CAGR: 12.00%

The global recombinant proteins market size is expected to reach USD 7.53 billion by 2034, according to a new study by Polaris Market Research. The report “Recombinant Proteins Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Product, Production Services), By Application, By End Use, By Region -Market Forecast, 2026 - 2034” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

Recombinant proteins market focuses on proteins that are commercially produced using recombinant DNA technology. These proteins are used for different applications such as therapeutics, diagnostics, research, biologics development, vaccines, and cell and gene therapy.

Significant growth in government funding, improved R&D investment by pharmaceutical companies, and the growing incidence of non-communicable and chronic diseases is anticipated to fuel the demand. In addition, the availability of a variety of innovations from human and animal sources and the increasing interest in biological products is expected to boost industry growth.

Other factors that are expected to support growth opportunities are the increasing focus on personalized medicine and protein therapeutics. The demand from a number of countries in Asia Pacific, such as India, China, Japan, and South Korea, is expected to impact the industry positively. However, the reduced cost of the product may be a barrier, limiting industry growth.

Recombinant Proteins Market Report Highlights

• The therapeutics segment dominated the market with 33.86% in 2025, as demand for effective and convenient treatments is expected to witness growth over the forecast period.
• The enzymes segment accounted for the significant revenue share of 11.24% in 2025 and is expected to continue its dominance owing to the usage of enzymes in many research domains such as wound repairs, oncology, and other diseases.
• The pharmaceutical & biotech companies segment is expected to spearhead revenue growth of 39.18% in 2025 since discovery, assay development, and process work all require recombinant proteins.
• Asia Pacific is expected to witness substantial growth of 15.32 % over the forecast period on account of several non-curable illnesses that are increasing across developing economies like India and China with increasing R&D initiatives.
• Major players operating in the industry include Abcam (part of Danaher Corporation), Abnova Corporation, Aviva Systems Biology Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Elevian Inc., Eli Lilly and Company, Elpiscience, Enzo Biochem Inc., GenScript, GigaGen Inc. (a Grifols company), Merck KGaA, Proteintech Group, Inc., RayBiotech Life, Inc., Shilpa Medicare Limited, Sino Biological Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific, Inc., and U-Protein Express B.V.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Recombinant Proteins Market Report

Recombinant Proteins Market report based on product & services, application, end-use, and region:

By Product & Services Outlook (Revenue - USD Billion, 2021 - 2034)

• Product
  • Cytokines & Growth Factors
    • Interferons (IFNs)
    • Interleukins (ILs)
    • Others
  • Antibodies
  • Immune Checkpoint Proteins
  • Virus Antigens
  • Enzymes
    • Kinases
    • Metabolic Enzymes
    • Others
  • Recombinant Regulatory Proteins
  • Hormones
  • Others
• Production Services

By Application Outlook (Revenue - USD Billion, 2021 - 2034)

• Drug Discovery & Development
• Therapeutics
  • Biologics
  • Vaccines
  • Cell & Gene Therapies
  • Others
• Research
• Others

By End-Use Outlook (Revenue - USD Billion, 2021 - 2034)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

By Regional Outlook (Revenue - USD Billion, 2021 - 2034)

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa